Lyell Immunopharma (LYEL)
NASDAQ:LYEL
Lyell Immunopharma (LYEL) Ownership Overview
47.41% Insiders
7.06% Mutual Funds
33.16% Other Institutional Investors
4.12% ETFs
8.25% Public Companies and
Individual Investors
The ownership structure of Lyell Immunopharma (LYEL) stock is a mix of institutional, retail, and individual investors. Approximately 44.34% of the company’s stock is owned by Institutional Investors, 47.41% is owned by Insiders, and 8.25% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 09, 2026 | xxxxxxxxxxxxx | $12499985 | |
Mar 09, 2026 | xxxxxxxxxxxxx | $12499985 | |
Feb 12, 2026 | xxxxxxxxxxxxx | $174372 | |
Feb 12, 2026 | xxxxxxxxxxxxx | $28910 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,811,199 | Insider | 16.35% | 72,870,125 | |
| 3,247,162 | Insider | 13.93% | 62,085,737 | |
| 3,247,162 | Insider | 13.93% | 62,085,737 | |
| 718,820 | Institution | 3.08% | 13,743,838 | |
| 692,551 | Institution | 2.97% | 13,241,575 | |
| 648,410 | Institution | 2.78% | 12,397,599 | |
| 336,370 | Insider | 1.44% | 6,431,394 | |
| 200,000 | Insider | 0.86% | 3,824,000 | |
| 109,489 | Institution | 0.47% | 2,093,430 | |
| 98,425 | Institution | 0.42% | 1,881,886 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 692,551 | Institution | 2.97% | 13,241,575 | |
| 648,410 | Institution | 2.78% | 12,397,599 | |
| 109,489 | Institution | 0.47% | 2,093,430 | |
| 71,141 | Institution | 0.31% | 1,360,216 | |
| 23,263 | Institution | 0.10% | 444,789 | |
| 21,220 | Institution | 0.09% | 405,726 | |
| 18,000 | Institution | 0.08% | 344,160 | |
| 14,319 | Institution | 0.06% | 273,779 | |
| 9,320 | Institution | 0.04% | 178,198 | |
| 9,238 | Institution | 0.04% | 176,631 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 537,261 | Institution | 2.31% | 12,894,264 | |
| 158,456 | Institution | 0.68% | 3,802,944 | |
| 68,543 | Institution | 0.29% | 1,423,638 | |
| 50,724 | Institution | 0.22% | 969,843 | |
| 43,493 | Institution | 0.19% | 831,586 | |
| 30,080 | Institution | 0.13% | 46,624 | |
| 23,103 | Institution | 0.10% | 554,472 | |
| 16,309 | Institution | 0.07% | 327,159 | |
| 15,113 | Institution | 0.06% | 313,897 | |
| 10,245 | Institution | 0.04% | 212,789 |
FAQ
Who Owns Lyell Immunopharma (LYEL)?
According to the latest TipRanks data, approximately 33.16% of the company's stock is held by institutional investors, 47.41% is held by insiders, and 8.25% is held by retail investors.
What percentage of Lyell Immunopharma (LYEL) stock is held by institutional investors?
According to the latest TipRanks data, approximately 33.16% of Lyell Immunopharma (LYEL) stock is held by institutional investors.
What percentage of Lyell Immunopharma (LYEL) stock is held by retail investors?
According to the latest TipRanks data, approximately 8.25% of Lyell Immunopharma (LYEL) stock is held by retail investors.
Who owns the most shares of Lyell Immunopharma (LYEL)?
Richard Klausner owns the most shares of Lyell Immunopharma (LYEL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.